primatron returns

Sorry guys but on a business trip to Melbourne and so cannot get on the computer.

Lets get down to hard facts:

Another announcement by PRR along the same line 4 out of 21 patients responded.
No release of the Independent Report
39 million (that is 20% of the company has changed hands with a 1 cent rise in price)


It sort of points to the fact that a significant level of selling was/is ready to come to the market on the release of this latest “news”. Also the action in the stock on the lead up to the trading halt should indicate caution since it is clear that parties are aware of things before they come to the market.

It also tells you that people were prepared to buy 39 million and you traders should get some comfort with this.

The question you all have to answer is whether or not the 39 million has gone to traders or longer term investors.

You will probably find that Taylor Collison (took placement at 5 cents) clients have been the significant sellers (probably nervous) but the buying support I assume is probably traders which will ultimately be bad for the company.

The facts do not change and all this attempt at hype by PRR is all lined up to the planned capital raising. Again expect this announcement in March.

My initial reaction is:

Why would Biomira not elect if the results were interpreted to be significant?
Are we all being fed the same information in another dress?
Again PRR is looking to get traders to support their shares but not releasing auditable Independent Assessment of the PhIIa trials.
We have not been given the Independent Assessment of the Significance of the trials.

Do not confuse the macerations of a company looking to raise money with that of a company with a real business.

PRR has now successfully managed to churn 20% of their stock from tired and disgruntle investors to new investors. How long the support remains is the big question.